Sirtex Medical Inc.

Sirtex Medical Inc. engages in the research, development, and commercialization of treatments for liver cancer using small particle technology. Its SIR-Spheres microspheres are biocompatible radio-active micro-spheres that contain yttrium and emit beta radiations, which are implanted using a syringe and travel via the blood stream. The microspheres act as transport vehicles to carry anticancer agents, such as ionising radiation, anticancer drugs or materials that generate heat within the cancer. It serves markets in Australia, the United States, the European Union, Hong Kong, Malaysia, Singapore, Thailand, Taiwan, India, Israel, Turkey, and Brazil. The company was incorporated in 2001 and is based in Woburn, Massachusetts with manufacturing facilities in Wilmington, Massachusetts. Sirtex Medical Inc. operates as a subsidiary of Sirtex Medical Limited.